Nicolette Sherman
Human Resources Officer en CERTARA, INC. .
Fortuna: 435 521 $ al 31/03/2024
Perfil
Nicolette D.
Sherman is currently the Chairman at Deirdres House and the Chief Human Resources Officer at Certara, Inc. She previously worked as the VP-North America Human Resources Operations at Sanofi Corp.
from 2008 to 2020 and as the Chief Human Resources Officer at Oyster Point Pharma, Inc. from 2020 to 2021.
Sherman has a graduate degree from Rutgers State University of New Jersey and a graduate degree from the University of Delaware.
She also has an undergraduate degree from Lehigh University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CERTARA, INC.
0.02% | 01/04/2024 | 24 358 ( 0.02% ) | 435 521 $ | 31/03/2024 |
Cargos activos de Nicolette Sherman
| Empresas | Cargo | Inicio |
|---|---|---|
| CERTARA, INC. | Human Resources Officer | 13/07/2021 |
| Deirdres House | Chairman | - |
Antiguos cargos conocidos de Nicolette Sherman.
| Empresas | Cargo | Fin |
|---|---|---|
| OYSR POIN | Human Resources Officer | 01/07/2021 |
| Sanofi Corp. | Corporate Officer/Principal | 01/04/2020 |
Formación de Nicolette Sherman.
| Rutgers State University of New Jersey | Graduate Degree |
| Lehigh University | Undergraduate Degree |
| University of Delaware | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CERTARA, INC. | Technology Services |
| Empresas privadas | 3 |
|---|---|
| Sanofi Corp. | |
Oyster Point Pharma, Inc.
 Oyster Point Pharma, Inc. Pharmaceuticals: MajorHealth Technology Oyster Point Pharma, Inc. engages in the development and commercialization of pharmaceutical therapies to treat ocular surface diseases. Its product candidate, OC-01, is a nicotinic acetylcholine receptor agonist, which is being developed as a nasal spray to treat the signs and symptoms of dry eye disease. The company was founded by Michael and is Ackermann in June 30, 2015 headquartered in Princeton, NJ. | Health Technology |
| Deirdres House |
- Bolsa de valores
- Insiders
- Nicolette Sherman
